Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Hims & Hers vs Found

Both scored on the same six-factor Match Score. Found wins this matchup with a 88 to 83 edge.

Hims & Hers

#17 · Grade B

People who want a familiar, app-driven consumer brand and fast nationwide onboarding.

Visit Hims & Hers
VS
Higher Match Score

Found

#2 · Grade B+

People who want the lowest price and behavior-change coaching bundled with medication.

Visit Found

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
80
96
Speed to Start
92
90
Formulary Match
76
80
Support Level
86
92
Flexibility
84
78
Transparency
82
90

Price, coverage & formulary

DetailHims & HersFound
Semaglutide$199/mo$129/mo
TirzepatideNot disclosed$129/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjectable onlyInjectable only
Match Score83 · B88 · B+
Winner: Found

Found edges out Hims & Hers, 88 to 83 on the default Match Score. A coaching-first program with aggressive, identical pricing on both molecules — the budget match to beat.

Hims & Hers is still a fair pick if its strengths line up with yours — best for: People who want a familiar, app-driven consumer brand and fast nationwide onboarding.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Hims & Hers reviewFull Found review

More head-to-heads

Or browse alternatives to Found and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.